Clinical parameter | FENDRR | Â | Chi-squared test P-value |
---|---|---|---|
 | High No. cases (n = 79) | Low No. cases (n = 79) |  |
Age (years) | Â | Â | 0.426 |
<50 | 35 | 40 | Â |
>50 | 44 | 39 | Â |
Gender | Â | Â | 0.255 |
Male | 44 | 51 | Â |
Female | 35 | 28 | Â |
Location | Â | Â | 0.452 |
Distal | 31 | 37 | Â |
Middle | 28 | 28 | Â |
Proximal | 20 | 14 | Â |
Size | Â | Â | 0.152 |
>5Â cm | 37 | 46 | Â |
<5Â cm | 42 | 33 | Â |
Histologic differentiation | Â | Â | 0.171 |
Well | 4 | 6 | Â |
Moderately | 34 | 21 | Â |
Poorly | 34 | 41 | Â |
Undifferentiated | 7 | 11 | Â |
Invasion depth | Â | Â | <0.001* |
T1 | 30 | 6 | Â |
T2 | 28 | 13 | Â |
T3 | 11 | 34 | Â |
T4 | 10 | 26 | Â |
TNM Stages | Â | Â | 0.001* |
I | 22 | 8 | Â |
II | 32 | 23 | Â |
III | 16 | 39 | Â |
IV | 9 | 9 | Â |
Lymphatic metastasis | Â | Â | 0.007* |
Yes | 33 | 50 | Â |
No | 46 | 29 | Â |
Regional lymph nodes | Â | Â | <0.001* |
PN0 | 47 | 28 | Â |
PN1 | 15 | 7 | Â |
PN2 | 10 | 27 | Â |
PN3 | 7 | 17 | Â |
Distant metastasis | Â | Â | 0.797 |
Yes | 8 | 9 | Â |
No | 71 | 70 | Â |